Interventional Cardiology and Angiology


Prevention of Restenosis - Drugs investigated for restenosis prevention

  • Thrombosis
    • Warfarin, heparin, low molecular weight heparin, hirudin, inhibitor of thrombin, aspirin, dipyridamole, throm-boxane inhibitor, prostacyclin, ticlopidine, GPIIb/IIIa.
  • Cell proliferation
    • ACE inhibitors, colchicine, HMG-CoA reductase inhibitor, angiopeptin, low molecular heparin, serotonin antagonists, cyto-static agents
  • Inflammation
    • Corticosteroids, nonsteroidal antiinflammatory drugs
  • Coronary vasospasm
    • Calcium antagonists
  • Lipid regulators
    • Omega-3 fatty acid, HMG-CoA reductase inhibitor

Universitätsklinikum Charité - Medizinische Fakultät der Humboldt-Universität zu Berlin, Campus Berlin-Buch
Franz-Volhard-Klinik
Wiltbergstraße 50, D - 13125 Berlin
Tel.: +49 30 9417 2996 - Fax: +49 30 9497 074
Letzte Änderung: 17.11.98 - © 1998 - webmaster